abstract |
The present disclosure provides antibodies that specifically bind to Mer tyrosine kinase (MERTK) (eg, human MERTK, or both human and mouse MERTK), and compositions comprising such antibodies, wherein the antibody comprises endothelial Activate MERTK signaling on cells. The present disclosure also provides a method for treating cancer by administering an antibody that specifically binds to MERTK and activates MERTK signaling on endothelial cells. [Selection] Figure 4 |